ARTICLE | Clinical News
Amgen reports Aranesp data
May 14, 2001 7:00 AM UTC
AMGN reported Phase I/II data from a 428-patient study showing that once weekly and once every other week treatment with Aranesp novel erythropoiesis stimulating protein gave similar efficacy in treat...